EP 2958909 A1 20151230 - BICYCLO 2,3-BENZODIAZEPINES AND SPIROCYCLICALLY SUBSTITUTED 2,3-BENZODIAZEPINES
Title (en)
BICYCLO 2,3-BENZODIAZEPINES AND SPIROCYCLICALLY SUBSTITUTED 2,3-BENZODIAZEPINES
Title (de)
BICYCLO- UND SPIROCYCLISCH SUBSTITUIERTE 2,3-BENZODIAZEPINE
Title (fr)
2,3-BENZODIAZÉPINES BICYCLO- ET SPIROCYCLOSUBSTITUÉES
Publication
Application
Priority
- DE 102013202678 A 20130219
- EP 2014052984 W 20140217
Abstract (en)
[origin: WO2014128067A1] The invention relates to BET protein-inhibiting, in particular BRD4-inhibiting, bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines of the general formula (I), to the pharmaceutical agents containing the compounds according to the invention, and to the prophylactic and therapeutic use thereof against hyper-proliferative diseases, in particular tumor diseases. The invention further relates to the use of BET protein inhibitors in benign hyperplasia, atherosclerotic diseases, sepsis, autoimmune diseases, vascular disorders, viral infections, neurodegenerative disorders, inflammatory disorders, and male fertility control.
IPC 8 full level
A61K 31/551 (2006.01); A61P 7/00 (2006.01); A61P 25/28 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 405/10 (2006.01); C07D 451/06 (2006.01); C07D 471/10 (2006.01); C07D 487/04 (2006.01); C07D 487/08 (2006.01); C07D 487/10 (2006.01); C07D 491/048 (2006.01)
CPC (source: EP US)
A61K 31/551 (2013.01 - EP US); A61P 7/00 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 13/08 (2017.12 - EP); A61P 15/16 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); C07D 245/06 (2013.01 - EP US); C07D 401/10 (2013.01 - EP US); C07D 403/10 (2013.01 - EP US); C07D 405/10 (2013.01 - EP US); C07D 451/06 (2013.01 - EP US); C07D 471/08 (2013.01 - EP US); C07D 471/10 (2013.01 - EP US); C07D 487/04 (2013.01 - EP US); C07D 487/08 (2013.01 - EP US); C07D 487/10 (2013.01 - EP US); C07D 491/048 (2013.01 - EP US); C07D 491/08 (2013.01 - EP US); C07D 491/107 (2013.01 - EP US); C07D 495/10 (2013.01 - EP US); C07D 498/08 (2013.01 - EP US); C07D 498/10 (2013.01 - EP US)
Citation (search report)
See references of WO 2014128067A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2014128067 A1 20140828; AP 2015008673 A0 20150831; AU 2014220838 A1 20150910; BR 112015019811 A2 20170718; CA 2901352 A1 20140828; CN 105263919 A 20160120; CR 20150426 A 20151020; DO P2015000200 A 20151130; EP 2958909 A1 20151230; HK 1214819 A1 20160805; IL 240434 A0 20150924; JP 2016511247 A 20160414; KR 20150119926 A 20151026; MA 38346 A3 20190329; MA 38346 B1 20190531; PH 12015501822 A1 20151207; SG 11201505979U A 20150929; TN 2015000354 A1 20170103; US 2016129011 A1 20160512
DOCDB simple family (application)
EP 2014052984 W 20140217; AP 2015008673 A 20140217; AU 2014220838 A 20140217; BR 112015019811 A 20140217; CA 2901352 A 20140217; CN 201480022272 A 20140217; CR 20150426 A 20150819; DO 2015000200 A 20150819; EP 14704594 A 20140217; HK 16102753 A 20160310; IL 24043415 A 20150809; JP 2015557453 A 20140217; KR 20157025482 A 20140217; MA 38346 A 20140217; PH 12015501822 A 20150818; SG 11201505979U A 20140217; TN 2015000354 A 20150818; US 201414772761 A 20140217